GM Advisory Group’s Guardant Health GH Stock Holding History

GM Advisory Group’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,250	Closed	-$281K	–	208
2021 Q3	$281K	Sell	2,250 -115	-5%	-$13.7K	0.03%	168
2021 Q2	$294K	Buy	2,365 +400	+20%	+$53.8K	0.03%	163
2021 Q1	$300K	Buy	+1,965	New	+$297K	0.04%	153

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

GM Advisory Group's GH Position: Q4 2021 in Review

GM Advisory Group sold out of Guardant Health (GH) in Q4 2021, closing a stake of 2,250 shares — an estimated $281K sold.

GM Advisory Group first reported a position in GH in Q1 2021 and held it in 3 quarters. The position peaked at $300K in Q1 2021. 396 funds tracked by Wall St. Rank hold GH as of Q4 2021.

GM Advisory Group reported no remaining Guardant Health position as of Q4 2021 after selling out during the quarter.
GM Advisory Group sold 2,250 Guardant Health shares in Q4 2021, an estimated $281K.
GM Advisory Group first reported a position in Guardant Health in Q1 2021 and held it in 3 quarters.
GM Advisory Group's Guardant Health position peaked at $300K in Q1 2021.
396 funds tracked by Wall St. Rank held Guardant Health as of Q4 2021.

Based on GM Advisory Group's 13F filing for Q4 2021, filed 10 Feb 2022.